Alerts and implant recalls

The U.S. Food and Drug Administration (FDA) is warning doctors and consumers that a supplement used to treat genetic disorders in children can cause serious harm and in some cases could lead to death. New York-based compounding firm Medisca recently issued a voluntary recall of certain lot numbers of its L-citrulline products and warned consumers [...]

Read More

Before reaching for a bottle of Tylenol, popping a DayQuil pill or downing a dose of Tylenol Cold and Flu this flu season, Americans should know these popular drugs and their generic counterparts may harm their liver. Acetaminophen effectively lowers fever and relieves minor aches and pains without stomach discomfort and heart issues associated with [...]

Read More

FDA officials will again review Pradaxa, one of the best-selling blood thinners on the market that is also linked to accidental, uncontrollable bleeding. The review by the U.S. Food and Drug Administration’s Mini-Sentinel initiative will compare post-trial results between Pradaxa (dabigatran), by drugmaker Boehringer Ingelheim, and its popular counterpart warfarin as a “one-time assessment of [...]

Read More

The U.S. Food and Drug Administration in early January approved a new pill from Bristol-Meyers Squibb Co. and AstraZeneca to treat Type 2 diabetes after previously rejecting the drug. FDA officials last week announced Farxiga (dapaglifozin) can now be marketed and sold in the U.S. It’s the agency’s first new approval in 2014. The risk [...]

Read More

Laura Yaeger has a proven track record when it comes to representing people harmed by dangerous drugs and medical devices. She has represented thousands of individuals and their families against drug and device manufacturers whose products harmed people. She excels at handling mass tort litigation and complex cases. Yaeger is a native Floridian and obtained [...]

Read More